Environmental air toxicants and genetic predispositions actively interact to exacerbate chronic respiratory disorders worldwide. Specifically, ground-level oxidant pollutants worsen morbidity in individuals with underlying genetic vulnerabilities. A landmark investigation now provides granular insights into spatially distinct molecular and cellular responses to ozone-induced lung injury during surfactant protein-C (SP-C) gene mutation. By utilizing spatial transcriptomic and proteomic analyses, investigators mapped how acute oxidant stress disrupts alveolar homeostasis. Consequently, these findings shed light on the mechanisms driving environmental disease exacerbation in vulnerable pulmonary parenchyma.

Understanding Ozone-Induced Lung Injury and Genetic Susceptibility

Genetic variants in the surfactant protein-C gene frequently cause familial pulmonary fibrosis and sporadic interstitial pneumonias. In particular, the misfolded pro-protein causes severe endoplasmic reticulum stress in alveolar type II epithelial cells. However, clinical presentation varies significantly among patients carrying identical mutations. Therefore, environmental co-factors play a decisive role in triggering clinical disease or driving acute exacerbations. Ambient ozone represents a ubiquitous airborne oxidant capable of inducing deep airway inflammation and epithelial oxidation. When inhaled, it generates reactive oxygen species in the epithelial lining fluid, damaging lipid bilayers and structural proteins.

In this preclinical study, researchers investigated how ozone exposure interacts with tamoxifen-induced SP-C mutation. They exposed experimental models to an environmental concentration of ozone for three hours, evaluating lungs before or after mutant protein induction. Consequently, this model allowed direct examination of gene-environment interactions. While ozone did not accelerate classical histological fibrotic collagen deposition at seven days, it substantially elevated systemic distress and overall mortality. Furthermore, the combined challenge amplified inducible nitric oxide synthase activation within inflammatory cells. Thus, environmental oxidants can alter cellular activation without necessarily accelerating macroscopic tissue remodeling.

Spatial Multi-Omics Unravels Distinct Alveolar Microenvironments

Traditional bulk sequencing often obscures critical localized responses within heterogenous pulmonary tissues. To overcome this limitation, investigators applied spatial transcriptomic and quantitative proteomic platforms. Specifically, they isolated CD68-positive alveolar macrophages and CD45-negative non-immune stromal cells across histologically distinct parenchymal regions. They compared directly injured areas with adjacent peri-injured parenchymal tissues in both air-exposed and ozone-exposed lungs. As a result, the authors resolved unique molecular microenvironments that previous methodologies failed to differentiate.

Importantly, the data revealed that ozone-induced signals are remarkably localized rather than uniform across the pulmonary lobule. Tissues directly sustaining epithelial disruption displayed starkly different molecular programs compared to neighboring preserved alveoli. For instance, cells located within the injury epicenter focused heavily on emergency defense cascades. In contrast, cells residing in peri-injured margins prioritized repair programs and lipid handling. Furthermore, spatial mapping demonstrated that the underlying SP-C mutation profoundly modified how these zones reacted to the oxidative insult. Consequently, spatial profiling highlights the absolute necessity of evaluating regional tissue architecture when investigating environmental toxicant exposure. Clinicians must recognize that focal cellular dysfunction often precedes widespread organ-level damage.

Divergent Macrophage Phenotypes in Injured and Peri-Injured Zones

Pulmonary macrophages serve as critical regulators of both tissue inflammation and fibrotic repair. In this study, CD68-positive macrophages demonstrated dramatic spatial heterogeneity after ozone challenge. Macrophages positioned directly within injured lung regions showed marked enrichment of mitochondrial metabolism genes and antioxidant defense pathways. Because reactive oxygen species threaten cellular viability, these cells upregulate endogenous detoxifying machinery to survive the acute toxic insult.

Conversely, macrophages situated in peri-injured zones adopted entirely different functional programs. These peripheral cells enriched pro-survival genes alongside active lipid metabolism pathways. In addition, phosphoproteomic profiling showed that ozone-dependent phospho-signaling in CD68 macrophages remained tightly restricted to these peri-injured regions. Therefore, spatial compartmentalization prevents diffuse, uncontrolled immune activation throughout healthy parenchyma.

Moreover, the researchers evaluated myeloid recruitment dynamics over time. Following ozone exposure in fibrosing mutant lungs, an influx of inflammatory Ly6C-high monocytes occurred at three days. Interestingly, ozone simultaneously dampened the standard expansion of CD4-positive and CD8-positive T lymphocytes typically observed in healthy uninduced lungs. This altered recruitment pattern demonstrates that pre-existing surfactant abnormalities suppress adaptive immune responses while favoring myeloid-driven inflammatory stress. Consequently, resident and recruited macrophages orchestrate discordant regional programs during environmental challenges.

Non-Immune Stromal Responses and Phospho-Signaling Cascades

Alveolar non-immune cells, including type II pneumocytes, endothelial cells, and fibroblasts, play fundamental roles during respiratory injury. In this investigation, CD45-negative cells exhibited extensive reprogramming following oxidant inhalation. Specifically, ozone induced prominent cellular senescence programs and cell-cycle regulatory pathways across all analyzed non-immune populations. Hence, acute oxidative stress rapidly halts cellular proliferation to prevent the replication of damaged genomic material.

Furthermore, non-immune cells residing within peri-injured zones displayed notable enrichment in metabolic adaptation and collagen remodeling genes. This finding suggests that fibroblasts and stromal elements in borderline regions actively prepare the extracellular matrix for structural stabilization. Additionally, global proteomic analysis revealed widespread phosphorylation signaling throughout CD45-negative populations, regardless of their immediate microenvironmental location. Unlike macrophages, non-immune structural cells mount a generalized kinase signaling cascade upon environmental exposure.

Nevertheless, evaluation at seven days demonstrated that cell proliferation markers, such as Ki67, and histological fibrosis scores were not elevated by ozone. Thus, the oxidant gas modified immediate signaling without accelerating overall fibrotic progression. However, the combination of genetic misfolding and pollutant stress substantially worsened clinical mortality. Therefore, toxic signaling cascades in structural cells may precipitate acute physiological decompensation without immediate histological scarring.

Translational Implications for Interstitial Lung Disease Management

These molecular insights carry profound clinical relevance for physicians managing interstitial lung disease and idiopathic pulmonary fibrosis. Clinical epidemiologists have repeatedly linked spikes in ambient ozone levels with acute respiratory hospitalizations and unexplained disease exacerbations. Patients suffering from underlying genetic surfactant mutations or subclinical alveolar epithelial dysfunction represent an exceptionally vulnerable demographic. While acute environmental exposures may not immediately worsen structural parenchymal fibrosis, they trigger severe microvascular and inflammatory distress.

Consequently, healthcare practitioners in heavily polluted urban environments must incorporate air quality counseling into routine clinical protocols. For example, advising vulnerable patients to limit outdoor exertion during peak afternoon ozone alerts can mitigate acute parenchymal insult. In addition, targeting inducible nitric oxide synthase activation or macrophage-specific mitochondrial stress could yield novel therapeutic interventions. Current antifibrotic therapies primarily target fibroblast proliferation and extracellular matrix accumulation. However, adjunctive strategies may need to focus on protecting alveolar epithelial survival and dampening aberrant myeloid recruitment during pollution episodes.

Ultimately, this study bridges basic environmental toxicology and clinical pulmonology. By defining how localized cellular niches respond to oxidative stress, investigators have uncovered novel biomarkers and pathway targets. Future clinical trials must explore whether antioxidant therapies or specialized environmental mitigations can preserve lung function in genetically susceptible cohorts.

How does ozone exposure interact with surfactant protein-C mutations to alter lung injury?

Ozone exposure acts as an environmental modifier rather than an immediate accelerator of structural fibrosis. When combined with mutant surfactant protein-C, ozone triggers marked influx of Ly6C-high monocytes and suppresses classical adaptive T-cell expansion. Additionally, the dual challenge enhances inducible nitric oxide synthase activation and escalates overall animal mortality. Consequently, the pollutant promotes dangerous localized oxidative stress and inflammatory signaling without immediately increasing collagen remodeling.

What are the spatially distinct macrophage responses observed in ozone-induced lung injury?

Spatial multi-omics reveals that macrophages adopt distinct phenotypic programs depending on microenvironmental localization. Specifically, macrophages within the injury epicenter enrich mitochondrial metabolism and antioxidant pathways to survive acute oxidant cytotoxicity. In contrast, macrophages in adjacent peri-injured zones upregulate pro-survival genes, active lipid metabolism pathways, and localized phospho-signaling cascades. Therefore, alveolar macrophages coordinate localized stress responses rather than uniform immune cascades across the damaged pulmonary lobule.

Why is this research clinically relevant for pulmonologists treating interstitial lung disease?

Ambient air pollution, particularly ground-level ozone, frequently triggers acute, life-threatening exacerbations in patients suffering from interstitial lung disease. This research demonstrates that oxidant pollutants induce cellular senescence, extensive non-immune phospho-signaling, and metabolic disruption in vulnerable lung tissues. Understanding these early localized molecular mechanisms enables clinicians to emphasize environmental avoidance strategies. Furthermore, these pathways highlight potential pharmacological targets, such as nitric oxide inhibition and antioxidant support, to prevent acute decompensation.

Disclaimer: This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Montgomery-Bowie CB et al. Spatially distinct molecular and immune responses to ozone exposure during mutant surfactant protein-C-induced lung injury. Inhal Toxicol. 2026 Oct 03. doi: 10.1080/08958378.2026.2738562. PMID: 42829339.
2. Johannson KA, Vittinghoff E, Lee K, et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure. Eur Respir J. 2014;43(4):1124-1131. doi: 10.1183/09031936.00122213.
3. Nguyen J, Deering-Rice CE, Armstrong BS, Massa C, Reilly CA, Venosa A. Parenchymal and inflammatory cell responses to single and repeated ozone exposure in healthy and surfactant protein-C mutant lung. Toxicol Sci. 2022;189(1):107-123. doi: 10.1093/toxsci/kfac074.
4. Singh N, Singh S. Interstitial lung diseases and air pollution: narrative review of literature. Pulm Ther. 2021;7(1):1-14. doi: 10.1007/s41030-021-00147-3.